MONASTERO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 11.347
EU - Europa 5.671
AS - Asia 5.096
SA - Sud America 921
AF - Africa 167
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 23.228
Nazione #
US - Stati Uniti d'America 11.184
SG - Singapore 1.956
RU - Federazione Russa 1.538
IT - Italia 1.515
CN - Cina 1.221
BR - Brasile 749
HK - Hong Kong 523
VN - Vietnam 515
DE - Germania 469
FI - Finlandia 396
PL - Polonia 334
UA - Ucraina 324
GB - Regno Unito 256
FR - Francia 252
IE - Irlanda 196
JP - Giappone 161
BD - Bangladesh 115
IN - India 110
KR - Corea 90
TR - Turchia 90
CA - Canada 72
SE - Svezia 72
NL - Olanda 69
IQ - Iraq 61
AR - Argentina 57
RO - Romania 47
AT - Austria 46
CI - Costa d'Avorio 45
MX - Messico 41
BE - Belgio 40
ZA - Sudafrica 37
EC - Ecuador 29
ID - Indonesia 29
PK - Pakistan 28
ES - Italia 27
MA - Marocco 27
IR - Iran 24
UZ - Uzbekistan 22
SA - Arabia Saudita 21
CO - Colombia 20
VE - Venezuela 19
MY - Malesia 18
AU - Australia 17
CH - Svizzera 15
JM - Giamaica 15
NP - Nepal 14
CL - Cile 13
GR - Grecia 13
AE - Emirati Arabi Uniti 12
JO - Giordania 12
LT - Lituania 12
BG - Bulgaria 11
DZ - Algeria 11
KE - Kenya 11
PE - Perù 11
TN - Tunisia 11
EG - Egitto 10
IL - Israele 8
KZ - Kazakistan 8
PY - Paraguay 8
BO - Bolivia 7
CZ - Repubblica Ceca 7
UY - Uruguay 7
AL - Albania 6
AZ - Azerbaigian 6
PA - Panama 6
PS - Palestinian Territory 6
BH - Bahrain 5
CR - Costa Rica 5
EU - Europa 5
LB - Libano 5
PH - Filippine 5
RS - Serbia 5
TW - Taiwan 5
AN - Antille olandesi 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
NI - Nicaragua 4
OM - Oman 4
PT - Portogallo 4
TH - Thailandia 4
BB - Barbados 3
KG - Kirghizistan 3
NG - Nigeria 3
QA - Qatar 3
TT - Trinidad e Tobago 3
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
LK - Sri Lanka 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 23.203
Città #
Ashburn 1.418
Singapore 1.343
Fairfield 1.290
Woodbridge 679
Chandler 633
Houston 606
San Jose 570
Wilmington 508
Seattle 505
Hong Kong 487
Cambridge 430
Dallas 420
Ann Arbor 337
Zgierz 304
Moscow 301
Palermo 301
Beijing 219
Dublin 195
Medford 193
Council Bluffs 189
Des Moines 174
Ho Chi Minh City 172
Santa Clara 167
New York 162
Jacksonville 160
Tokyo 154
Lauterbourg 140
Frankfurt am Main 139
Los Angeles 137
Hanoi 130
Altamura 126
Princeton 120
Nanjing 112
Lawrence 100
Rome 97
Hefei 95
Milan 90
Dearborn 87
Boardman 83
San Diego 76
São Paulo 73
Buffalo 70
Tulsa 59
Helsinki 58
Ludwigshafen am Rhein 57
London 49
Shenyang 49
Orem 47
Abidjan 45
Chicago 43
The Dalles 43
Brussels 38
Izmir 38
Jinan 38
Nanchang 38
Hebei 34
Nuremberg 34
Tianjin 33
Changsha 32
Atlanta 30
Rio de Janeiro 27
San Paolo di Civitate 26
Chennai 25
Baghdad 24
Guangzhou 23
Ottawa 23
Phoenix 23
Belo Horizonte 22
Da Nang 22
Jiaxing 22
Vienna 20
Warsaw 20
Amsterdam 19
Haiphong 19
Saint Petersburg 19
Seongnam 19
Columbus 18
Falls Church 18
Kumar 18
Munich 18
Paris 18
Denver 17
Johannesburg 17
Shanghai 17
Tashkent 17
Brasília 16
Zhengzhou 16
Norwalk 15
Lappeenranta 14
Montreal 14
Stockholm 14
Tehran 14
Turin 14
Central 13
Manchester 13
Verona 13
Biên Hòa 12
Bologna 12
City of London 12
Curitiba 12
Totale 15.072
Nome #
Studio di validazione dell'ACE-R in lingua italiana nella popolazione degli young-old e degli old-old 321
A systematic review of neuropsychiatric symptoms in mild cognitive impairment 303
Ageing: From inflammation to cancer 297
Movements execution in amnestic mild cognitive impairment and Alzheimer's disease. 293
The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI) 292
Cognitive impairment in Behcet’s disease patients without overt neurological involvement 282
Double negative (CD19(+)IgG(+)IgD(-)CD27(-)) B lymphocytes: A new insight from telomerase in healthy elderly, in centenarian offspring and in Alzheimer's disease patients. 280
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment 270
Effects of levodopa oral bolus on the kinematics of the pointing movements in Parkinson's disease patients. 267
Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily 258
Interictal executive dysfunction in migraineurs without aura: relationship with duration and intensity of attacks. 256
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 251
FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease 249
[3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions 248
Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabùt Aging Project 246
Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: Two case reports 244
Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study 238
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 238
Double Negative (IgG+IgD-CD27-) B Cells are Increased in a Cohort of Moderate-Severe Alzheimer’s Disease Patients and Show a Pro-Inflammatory Trafficking Receptor Phenotype 237
Prognosis of migraine headaches in adolescents: a 10-year follow-up study. 233
Comorbidity between depressive symptoms and migraine: preliminary data from the Zabút Aging Project 229
Association between plasma lipid levels and migraine in subjects aged > or =50 years: preliminary data from the Zabùt Aging Project 228
Isolated, subtle, neurological abnormalities in neurologically and cognitively healthy aging subjects 227
Alzheimer’s disease and infections, where we stand and where we go 225
Can Alzheimer disease be a form of type 3 diabetes? 223
Mild cognitive impairment: a systematic review 223
Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS) 221
Visuospatial learning is fostered in migraine: evidence by a neuropsychological study 220
Prevalence and profile of mild cognitive impairment in Parkinson's disease 219
Dietary Supplements as Surrogate of Mediterranean Diet in Healthy Smoking Subjects 214
I disturbi comportamentali “clinicamente rilevanti” nella demenza vascolare, nella demenza a corpi di Lewy e nella demenza di Alzheimer: studio su 921 pazienti anziani 213
Frequency and correlates of Subjective Memory Complaints in Parkinson’s disease with and without Mild Cognitive Impairment : data from the Parkinson’s disease cognitive impairment study 213
Visual hallucinations and agitation in Alzheimer's Disease due to memantine: report of three cases 211
Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project 210
β-glucans: Ex vivo inflammatory and oxidative stress results after pasta intake 207
Metabolomic analysis of plasma from Alzheimer disease patients 206
Double Negative (CD19+IgG+IgD-CD27-) B Lymphocytes: A New Insight from Telomerase in Healthy Elderly, in Centenarian Offspring, and in Alzheimer’s Disease Patients 205
No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. 204
Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. 203
Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease 200
The symptom of low mood in the prodromal stage of mild cognitive impairment and dementia: a cohort study of a community dwelling elderly population 198
SHIP2: A ‘‘NEW’’ Insulin Pathway Target for Aging Research 194
Mild behavioral impairment in Parkinson's disease: Data from the Parkinson's disease cognitive impairment study (PACOS) 193
The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction 189
A new intraoral device to home assist Parkinson’s disease patients by distant control 188
Effects of 8-OH-DPAT on open field performance of young and aged rats prenatally exposed to diazepam: a tool to rveal 5-HT1a receptor function 188
Chronic headache and body mass index: a case-control study. 187
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. 185
Predictors of progression from mild cognitive impairment to Alzheimer disease 183
Anxiety disorder, depression and chronic daily headache: a case-control study. 183
Mediterranean diet and longevity in Sicily: survey in a Sicani Mountains population 183
The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment 182
Cognitive performance in elderly patients undergoing carotid endarterectomy or carotid artery stenting: A twelve-month follow-up study 181
Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment 177
Migraine headaches in adolescents: a five-year follow-up study 177
Electrocortical networks in Parkinson's disease patients with Mild Cognitive Impairment. The PaCoS study 176
Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study 175
Comment on "Sleep disturbances and later cognitive status: a multi-centre study" 175
Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. 174
Five-year longitudinal study of juvenile migraine headaches 171
Validation study of the Italian Addenbrooke's Cognitive Examination Revised in a young-old and old-old population 170
Incidence of mild cognitive impairment and dementia in Parkinson's disease: The Parkinson's disease cognitive impairment study 167
Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease 166
TRANS-CRANIAL MRI-GUIDED FOCUSED ULTRASOUND SURGERY (TCMRGFUS): PRELIMINARY ITALIAN (AND WORLD-FIRST) EXPERIENCE AT 1,5 TESLA (first 3 cases treated) 164
Vascular risk factors in mild cognitive impairment subtypes. Findings from the ReGAl project 163
HETEROGENEITY IN RISK FACTORS FOR COGNITIVE IMPAIRMENT, NO DEMENTIA: Population-Based Longitudinal Study From the Kungsholmen Project. 163
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 Lockdown 163
Migraine without aura as a possible sign of covert neurological involvement in Behcet's disease: a case-control study 158
Behavioral and psychological effects of coronavirus disease-19 quarantine in patients with dementia 158
Cardiovascular autonomic function and MCI in Parkinson's disease 157
Prevalence of headache in patients with Behçet's disease without overt neurological involvement 156
POST-THALAMOTOMY NEUROFUNCTIONAL FINDINGS ON PATIENTS TREATED WITH TRANS-CRANIAL MAGNETIC RESONANCE GUIDED FOCUSED ULTRASOUND SURGERY (TCMRGFUS): PRELIMINARY RESULTS 153
Oral health status and periodontitis in Alzheimer's disease patients: A case control Study in a Sicilian rural community 152
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 152
Malattie delle meningi e neurolue 150
Tower of London test: a comparison between conventional statistic approach and modelling based on artificial neural network in differentiating fronto-temporal dementia from Alzheimer's disease 150
ORAL HEALTH STATUS AND PERIODONTITIS IN ALZHEIMER'S DISEASE:A POPULATION-BASED, CASE-CONTROL STUDY FROM THE ZABUT AGING PROJECT 150
Erratum: FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease (Analytical and Bioanalytical Chemistry DOI: 10.1007/s00216-015-9229-6) 150
Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project 148
Apoe genotype influences the biological effects of AChe inhibitors on platelet APP metabolism 147
Risk factors for cognitive impairment in subjecys with Behcet's disease 146
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations 146
No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease 146
A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide 144
Focus of endothelial glycocalyx dysfunction in ischemic stroke and Alzheimer’s disease: possible intervention strategies 143
Mild cognitive impairment predicts the onset of Sarcopenia: a longitudinal analysis from the English Longitudinal Study on Ageing 141
Preclinical Dementia: An Italian Multicentre Study on Amnestic Mild Cognitive Impairment 140
Red ear syndrome and migraine: report of eight cases. 140
Voxel-Based Morphomerty study in patients with amnestic Mild Cognitive Impairment and Alzheimer's Disease: population-based data from the Zabùt Aging Project 138
Metabolic syndrome, mild cognitive impairment and dementia: data from the cognitive impairment through aging 135
Intracerebral haemorrhage associated with sildenafil citrate 134
Amyloid precursor protein in platelets of patients with Alzheimer disease: Effect of acetylcholinesterase inhibitor treatment 132
Encefaliti 131
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 131
Diagnosis and therapeutic management of primary headache in an emergency setting 130
Cognitive deficits in beta-thalassemia major 130
Enalapril prophylaxis for migraine with aura 127
Migraine, tension type headache and body mass index. Is there any relationship? 126
The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey 126
AChR-seropositive myasthenia gravis in muscular dystrophy: diagnostic pitfalls and clinical management challenges 123
Totale 19.109
Categoria #
all - tutte 84.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 0 0 0 0 0 0 0 0 0 0 127 164
2021/20221.426 83 286 47 66 52 53 62 79 166 175 81 276
2022/20231.971 185 398 47 192 158 311 137 136 176 82 105 44
2023/20241.007 61 108 43 73 77 187 103 71 18 42 42 182
2024/20252.925 85 203 178 259 119 108 232 202 276 325 339 599
2025/20269.173 710 237 802 753 887 1.341 1.328 950 762 1.013 390 0
Totale 24.119